X
Xenetic Biosciences, Inc.XBIO
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The Company's proprietary DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in cancer.
US StocksHealthcareSmall CapBiotechnology
XBIO の価格トレンド
Xenetic Biosciences, Inc. · TradingView フルチャート
NASDAQ:XBIO